Iothalamate meglumine
Angio-conray, Conray, Cysto-conray, Vascoray (iothalamate meglumine) is a small molecule pharmaceutical. Iothalamate meglumine was first approved as Conray on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Conray, Cysto-conray (discontinued: Angio-conray, Conray)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Iothalamate meglumine
Iothalamate meglumine
+
Iothalamate sodium
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| VASCORAY | Mallinckrodt | N-016783 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| conray | New Drug Application | 2021-01-01 |
| cysto-conray ii | New Drug Application | 2020-12-31 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | IOTHALAMATE MEGLUMINE |
| INN | iotalamic acid |
| Description | Iotalamic acid is an organic molecular entity. |
| Classification | Small molecule |
| Drug class | iodine-containing contrast media |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |
Identifiers
| PDB | — |
| CAS-ID | 2276-90-6 |
| RxCUI | 1546451 |
| ChEMBL ID | CHEMBL1201125 |
| ChEBI ID | — |
| PubChem CID | 3737 |
| DrugBank | DB09133 |
| UNII ID | 16CHD79MIX (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 138 documents
View more details
Safety
Black-box Warning
Black-box warning for: Conray, Cysto-conray ii
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
5 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more
